Company Profile
Updated: 28-OCT-09Pierre Fabre Medicament S.A.S.
International Private company
45 Pl. Abel Gance, Boulogne Billancourt, F-92100, France
()33 01 49 10 80 00, 33 01 49 10 01 44 fax, http://www.pierre-fabre.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture of pharmaceutical preparations for the following therapeutic areas: cancerology, urology, cardiology, psychiatry, phlebology, pneumology, infectiology, gynaecology and rhumatology
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Cypress Gains Additional Rights In Pierre Fabre Milnacipran Deal.
BIOWORLD Today; 11/4/2009; 1053 words; ...its milnacipran agreement with Pierre Fabre Medicament SA. Signed in August 2001, the...chronic pain syndromes in the U.S. and Canada. That agreement...included an up-front payment to Pierre Fabre and potential milestone payments...
Cypress, Organon Mull Future Of Mirtazapine Collaboration.
BIOWORLD Today; 11/3/2009; 947 words; ...2001, after licensing it from Pierre Fabre Medicament SA, a division of Paris-based bioMerieux Pierre Fabre. Used to treat depression in more...has been marketed outside the U.S. since 1997. With partner Forest...
Cypress' Stock Plunges After Phase III Miss In Fibromyalgia.
BIOWORLD Today; 11/3/2009; 1427 words; ...represents Cypress's lead clinical candidate...licensing it from Pierre Fabre Medicament SA, a division of...based bioMerieux Pierre Fabre. Used to treat depression...marketed outside the U.S. since 1997. After...Cypress signed over U.S. development and...
Novacea Gains Rights To Oral Vinorelbine From Pierre Fabre.
BIOWORLD Today; 11/3/2009; 1126 words; ...by French company Pierre Fabre Medicament SA. The deal moves the privately...lung cancer, was designed by Pierre-Fabre to demonstrate similar clinical...manufacturing, which will be conducted at Pierre-Fabre's facility. In terms of the prospective...
Cypress Shares Soar On Positive Phase III Data In Fibromyalgia.
BIOWORLD Today; 11/3/2009; 1263 words; ...from a European trial conducted by Pierre Fabre Medicament SA, a division of Paris-based bioMerieux Pierre Fabre, from which Cypress licensed rights...has been marketed outside the U.S. for depression since 1997, but...
Recent News Articles
- Pierre Fabre Medicament and Forest Laboratories to Collaborate on Development and Commercialization of F2695 for Depression.
Biotech Week - January 07, 2009 - Pierre Fabre Medicament and Forest Laboratories to Collaborate on Development and Commercialization of F2695 for Depression.
PR Newswire - December 22, 2008 - Pierre Fabre submits MAA for milnacipran on strong Ph III data.(Pierre Fabre Medicament)(Market Authorization Application)(Brief article)
Pharma Marketletter - June 16, 2008 - Pierre Fabre to distribute Zambon's antibiotics in Germany.(Pierre Fabre Medicament S.A.)(Brief article)
Pharma Marketletter - February 26, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning